{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:08:37Z","timestamp":1791144517483,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.canlet.2024.217060","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T20:17:39Z","timestamp":1718396259000},"page":"217060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["HIF-2\u03b1 inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment"],"prefix":"10.1016","volume":"597","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.canlet.2024.217060_bib1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa1902328","article-title":"Asciminib in chronic myeloid leukemia after ABL kinase inhibitor failure","volume":"381","author":"Hughes","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.canlet.2024.217060_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrclinonc.2016.139","article-title":"Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?","volume":"14","author":"Rosti","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217060_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and resistance to BCR-ABL1-targeted therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.canlet.2024.217060_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","article-title":"The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML","volume":"20","author":"Vetrie","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2024.217060_bib5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217060_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.canlet.2024.217060_bib7","article-title":"SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming","volume":"26","author":"Xu","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"7495","key":"10.1016\/j.canlet.2024.217060_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canlet.2024.217060_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ncb2730","article-title":"Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment","volume":"15","author":"Nombela-Arrieta","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217060_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.10.005","article-title":"Advances in hypoxia-inducible factor biology","volume":"27","author":"Choudhry","year":"2018","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217060_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors--similar but not identical","volume":"29","author":"Loboda","year":"2010","journal-title":"Mol. Cell."},{"issue":"3","key":"10.1016\/j.canlet.2024.217060_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1alpha level is essential for hematopoietic stem cells","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.canlet.2024.217060_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.canlet.2024.217060_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2016-10-745588","article-title":"Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine","volume":"130","author":"Cheloni","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.canlet.2024.217060_bib15","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.canlet.2024.217060_bib16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2013-02-484923","article-title":"Hif-2\u03b1 is not essential for cell-autonomous hematopoietic stem cell maintenance","volume":"122","author":"Guitart","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2024.217060_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.stem.2013.08.011","article-title":"HIF-2\u03b1 protects human hematopoietic stem\/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Rouault-Pierre","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.canlet.2024.217060_bib18","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2006-0920","article-title":"Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations","volume":"91","author":"Pollard","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7627","key":"10.1016\/j.canlet.2024.217060_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"7627","key":"10.1016\/j.canlet.2024.217060_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.canlet.2024.217060_bib21","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.canlet.2024.217060_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2024.217060_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-020-00446-7","article-title":"Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.canlet.2024.217060_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s43018-020-0086-7","article-title":"Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2024.217060_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cytogfr.2018.08.004","article-title":"The cytokine network in acute myeloid leukemia (AML): a focus on pro- and anti-inflammatory mediators","volume":"43","author":"Binder","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.canlet.2024.217060_bib26","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3324\/haematol.2019.239913","article-title":"Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression","volume":"106","author":"Solimando","year":"2021","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.canlet.2024.217060_bib27","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/2159-8290.CD-17-1203","article-title":"Pathobiological pseudohypoxia as a putative mechanism underlying myelodysplastic syndromes","volume":"8","author":"Hayashi","year":"2018","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.canlet.2024.217060_bib28","first-page":"818","article-title":"[Role of HIF1A in the development of myelodysplastic syndromes]","volume":"60","author":"Hayashi","year":"2019","journal-title":"[Rinsho ketsueki] Jpn. J. Clin. Hematol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217060_bib29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3324\/haematol.2009.015628","article-title":"Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells","volume":"95","author":"Martin","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.canlet.2024.217060_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.canlet.2024.217060_bib31","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"40","key":"10.1016\/j.canlet.2024.217060_bib32","doi-asserted-by":"crossref","first-page":"E2707","DOI":"10.1073\/pnas.1214019109","article-title":"Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells","volume":"109","author":"Schito","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"21","key":"10.1016\/j.canlet.2024.217060_bib33","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2014-10-607267","article-title":"The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viability","volume":"125","author":"Krock","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.canlet.2024.217060_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1\u03b1 eliminates cancer stem cells in hematological malignancies","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.canlet.2024.217060_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.leukres.2010.10.020","article-title":"Hypoxia-inducible factor-1\u03b1 protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia","volume":"35","author":"Deeb","year":"2011","journal-title":"Leuk. Res."},{"issue":"10","key":"10.1016\/j.canlet.2024.217060_bib36","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/leu.2015.102","article-title":"Hypoxia inducible factor (HIF)-2\u03b1 accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML","volume":"29","author":"Forristal","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.canlet.2024.217060_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/CIRCRESAHA.117.311983","article-title":"Inositol polyphosphate multikinase inhibits angiogenesis via inositol pentakisphosphate-induced HIF-1\u03b1 degradation","volume":"122","author":"Fu","year":"2018","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217060_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020155","article-title":"Hypoxia pathway proteins in normal and malignant hematopoiesis","volume":"8","author":"Wielockx","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.canlet.2024.217060_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051103","article-title":"The role of deubiquitinating enzymes in hematopoiesis and hematological malignancies","volume":"12","author":"Sarodaya","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.canlet.2024.217060_bib40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/leu.2016.34","article-title":"TGF-\u03b1 and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy","volume":"30","author":"Nievergall","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.canlet.2024.217060_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10456-011-9241-1","article-title":"Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion","volume":"15","author":"Mineo","year":"2012","journal-title":"Angiogenesis"}],"updated-by":[{"DOI":"10.1016\/j.canlet.2024.217435","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000}}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524004543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524004543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:57:43Z","timestamp":1760741863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524004543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"alternative-id":["S0304383524004543"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217060","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIF-2\u03b1 inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217060"}}